Glycemic variability in abdominally obese men with normal glucose tolerance as assessed by continuous glucose monitoring system

Obesity

Volumn 19, Issue 8, 2011, Pages 1616-1622

  Ma, Chun Ming ^a   Yin, Fu Zai ^a   Wang, Rui ^a   Qin, Chun Mei ^a   Liu, Bo ^a   Lou, Dong Hui ^a   Lu, Qiang ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ABDOMINAL OBESITY; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD GLUCOSE MONITORING; CAROTID ATHEROSCLEROSIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC VARIABILITY; HUMAN; MALE; MEAN AMPLITUDE OF GLUCOSE EXCURSION; METABOLIC PARAMETERS; STANDARD DEVIATION OF BLOOD GLUCOSE; WAIST CIRCUMFERENCE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; GLUCOSE INTOLERANCE; HUMANS; MALE; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; OBESITY, ABDOMINAL; REFERENCE VALUES; TUNICA INTIMA; TUNICA MEDIA; WAIST CIRCUMFERENCE;

LAKE VICTORIA MARBURGVIRUS;

EID: 79960848807     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.5     Document Type: Article

References (38)

1. Monnier L, Mas E, Ginet C et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
2. Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab 2010;12: 288-298.
3. Meyfroidt G, Keenan DM, Wang X et al. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010;38:1021-1029.
4. Duncan AE, Abd-Elsayed A, Maheshwari A et al. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology 2010;112:860-871.
5. Maia FF, Araújo LR. Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients. Diabetes Res Clin Pract 2007;75:30-34. (Pubitemid 44856023)
6. Bonakdaran S, Rajabian R. Prevalence and extent of glycemic excursions in well-controlled patients with type 2 diabetes mellitus using continuous glucose-monitoring system. Indian J Med Sci 2009;63:66-71.
7. Service FJ, Molnar GD, Rosevear JW et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
8. Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2008;2:1094-1100.
9. Hanefeld M, Koehler C, Hoffmann C et al. Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes. Diabet Med 2010;27:175-180.
10. Kang Y, Lu JM, Sun JF et al. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance]. Zhonghua Yi Xue Za Zhi 2009;89:669-672.
11. Yang W, Lu J, Weng J et al.; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-1101.
12. Ko GT, Chan JC, Chow CC et al. Effects of obesity on the conversion from normal glucose tolerance to diabetes in Hong Kong Chinese. Obes Res 2004;12:889-895. (Pubitemid 41202388)
13. de Groot MR, Banga JD. Non invasive ultrasound measurement of intimamedia thickness. A tool to measure early atherosclerosis. Eur J Vasc Surg 1994;8:257-263. (Pubitemid 24133128)
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:S55-60.
15. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062. (Pubitemid 41338752)
16. Gross TM, Mastrototaro JJ. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2000;2 Suppl 1:S19-S26. (Pubitemid 32107468)
17. Esposito K, Ciotola M, Carleo D et al. Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. J Clin Endocrinol Metab 2008;93:1345-1350. (Pubitemid 351519731)
18. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-1490. (Pubitemid 44127568)
19. Service FJ, O'Brien PC, Rizza RA. Measurements of glucose control. Diabetes Care 1987;10:225-237. (Pubitemid 17065817)
20. Kohnert KD, Augstein P, Zander E et al. Glycemic variability correlates strongly with postprandial-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 2009;32:1058-1062.
21. Bruckert E. [Abdominal obesity: a health threat]. Presse Med 2008;37: 1407-1414.
22. Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF. Prolonged elevation of plasma free fatty acids impairs pancreatic-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 2000;49:399-408. (Pubitemid 30131785)
23. Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003;52:2490-2496. (Pubitemid 37210536)
24. Stumvoll M, Mitrakou A, Pimenta W et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301. (Pubitemid 30131733)
25. Kahn SE, Prigeon RL, Schwartz RS et al. Obesity, body fat distribution, insulin sensitivity and Islet-cell function as explanations for metabolic diversity. J Nutr 2001;131:354S-360S. (Pubitemid 32115380)
26. Cremer GM, Molnar GD, Taylor WF et al. Studies of diabetic instability. II. Tests of insulinogenic reserve with infusions of arginine, glucagon, epinephrine, and saline. Metabolism 1971;20:1083-1098.
27. Weir GC, Bonner-Weir S. Five stages of evolving-cell dysfunction during progression to diabetes. Diabetes 2004;53 Suppl 3:S16-S21. (Pubitemid 39564517)
28. Chen XM, Zhang Y, Shen XP et al. Correlation between glucose fluctuations and carotid intima-media thickness in type 2 diabetes. Diabetes Res Clin Pract 2010;90:95-99.
29. Hu Y, Liu W, Huang R, Zhang X. Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes. Atherosclerosis 2010;210:302-306.
30. El-Osta A, Brasacchio D, Yao D et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008;205:2409-2417.
31. Zheng FP, Wang Z, Li H et al. [Correlation between the amplitude of glucose excursion and plasma 8-iso prostaglandin F2alpha level in subjects with different types of glucose regulation]. Zhonghua Yi Xue Za Zhi 2009;89: 651-654.
32. Buscemi S, Re A, Batsis JA et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Diabet Med 2010;27:872-878.
33. Décordé K, Ventura E, Lacan D et al. An SOD rich melon extract Extramel prevents aortic lipids and liver steatosis in diet-induced model of atherosclerosis. Nutr Metab Cardiovasc Dis 2010;20:301-307.
34. Gokce N, Keaney JF Jr, Hunter LM et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002;105:1567-1572. (Pubitemid 34297634)
35. Halkjaer J, Tjønneland A, Overvad K, Sørensen TI. Dietary predictors of 5-year changes in waist circumference. J Am Diet Assoc 2009;109: 1356-1366.
36. Smith KJ, McNaughton SA, Gall SL et al. Takeaway food consumption and its associations with diet quality and abdominal obesity: a cross-sectional study of young adults. Int J Behav Nutr Phys Act 2009;6:29.
37. Graff MR, Gross TM, Juth SE, Charlson J. How well are individuals on intensive insulin therapy counting carbohydrates? Diabetes Res Clin Pract 2000;50:238-239.
38. Kildegaard J, Christensen TF, Hejlesen OK. Sources of glycemic variability-what type of technology is needed? J Diabetes Sci Technol 2009;3: 986-991.